161 related articles for article (PubMed ID: 2410864)
1. [Bone scintigraphy in assessing the success of chemotherapy in osteosarcoma].
Knop J; Stritzke P; Montz R; Delling G; Winkler K
Nuklearmedizin; 1985 Apr; 24(2):75-81. PubMed ID: 2410864
[TBL] [Abstract][Full Text] [Related]
2. [Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
Bielack S; Knop J; Delling G; Winkler K
Nuklearmedizin; 1988 Dec; 27(6):237-41. PubMed ID: 2464164
[TBL] [Abstract][Full Text] [Related]
3. [Nuclear medicine prediction of histologic tumor response of osteosarcoma].
Knop J; Delling G; Salzer-Kuntschik M; Berberich R; Feine U; Feistel H; Ladenstein R; Müller-Schauenburg W; Schober O; Szabo Z
Klin Padiatr; 1989; 201(4):285-92. PubMed ID: 2674533
[TBL] [Abstract][Full Text] [Related]
4. Histomorphometric changes of osteosarcoma after chemotherapy. Correlation with 99mTc methylene diphosphonate functional imaging.
Sommer HJ; Knop J; Heise U; Winkler K; Delling G
Cancer; 1987 Jan; 59(2):252-8. PubMed ID: 3467818
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology.
Knop J; Delling G; Heise U; Winkler K
Skeletal Radiol; 1990; 19(3):165-72. PubMed ID: 2185556
[TBL] [Abstract][Full Text] [Related]
6. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
[TBL] [Abstract][Full Text] [Related]
7. Total body bone scan in the evaluation of tumor response to preoperative chemotherapy in the treatment of osteosarcoma.
Manfrini M; Rimondi E; Bruno A; Capanna R; Albisinni U; Picci P; Bacci G; Gaiani L; Tarozzi C
Chir Organi Mov; 1990; 75(4):325-30. PubMed ID: 2098218
[TBL] [Abstract][Full Text] [Related]
8. [Clinical observation of diffuse renal accumulation of 99mTc-MDP].
Takeji H; Sui O; Shimazu H; Watanabe N; Kawaguchi K; Kawahara Y; Komatsu Y; Yoshida S
Rinsho Hoshasen; 1984 Aug; 29(8):875-9. PubMed ID: 6210380
[No Abstract] [Full Text] [Related]
9. Parametric imaging of 99mTc methylene diphosphonate biokinetics in osteosarcoma for preoperative evaluation of chemotherapy-induced necrosis.
Knop J; Delling G; Heise U; Winkler K
Chir Organi Mov; 1990; 75(1 Suppl):36-7. PubMed ID: 2249552
[No Abstract] [Full Text] [Related]
10. Quantitative thallium-201 scintigraphy in childhood osteosarcoma: Comparison with technetuim-99m MDP and magnetic resonance imaging in the evaluation of chemotherapeutic response.
Ilhan IE; Vural G; Berberoglu S; Kapucuoglu N; Cila A; Eke S
Pediatr Hematol Oncol; 2005 Mar; 22(2):153-62. PubMed ID: 15805001
[TBL] [Abstract][Full Text] [Related]
11. The angiographic response of osteosarcoma following pre-operative chemotherapy.
Kumpan W; Lechner G; Wittich GR; Salzer-Kuntschik M; Delling G; Kotz R; Hajek P; Sekera J
Skeletal Radiol; 1986; 15(2):96-102. PubMed ID: 2421415
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM
Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696
[TBL] [Abstract][Full Text] [Related]
13. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
Kubo T; Furuta T; Sakuda T; Ochi M; Adachi N
Medicine (Baltimore); 2018 Dec; 97(51):e13308. PubMed ID: 30572434
[TBL] [Abstract][Full Text] [Related]
14. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy.
Ozcan Z; Burak Z; Kumanlioğlu K; Sabah D; Başdemir G; Bilkay B; Cetingül N; Ozkiliç H
Nucl Med Commun; 1999 Jan; 20(1):41-8. PubMed ID: 9949412
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
Honda H; Oshiumi Y; Kamoi I; Ichiya Y; Wada M; Matsuura K
Kaku Igaku; 1981 Nov; 18(9):1315-9. PubMed ID: 6461790
[No Abstract] [Full Text] [Related]
16. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.
Ramanna L; Waxman A; Binney G; Waxman S; Mirra J; Rosen G
J Nucl Med; 1990 May; 31(5):567-72. PubMed ID: 2341892
[TBL] [Abstract][Full Text] [Related]
17. Serial thallium-201 scintigraphy in osteosarcoma. Correlation with tumor necrosis after preoperative chemotherapy.
Rosen G; Loren GJ; Brien EW; Ramana L; Waxman A; Lowenbraun S; Eckardt JJ; Eilber F; Menendez L; Mirra JM
Clin Orthop Relat Res; 1993 Aug; (293):302-6. PubMed ID: 8393392
[TBL] [Abstract][Full Text] [Related]
18. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients.
Winderen M; Stenwig AE; Solheim OP; Saeter G; Aas M
Acta Orthop Scand Suppl; 1999 Jun; 285():11-7. PubMed ID: 10429616
[No Abstract] [Full Text] [Related]
19. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma.
Ohtomo K; Terui S; Yokoyama R; Abe H; Terauchi T; Maeda G; Beppu Y; Fukuma H
J Nucl Med; 1996 Sep; 37(9):1444-8. PubMed ID: 8790189
[TBL] [Abstract][Full Text] [Related]
20. [The effect of chemotherapy on the retention of 99mTc-methylenediphosphonate by the osteogenic sarcoma of the mouse (author's transl)].
Senekowitsch R; Kriegel H
Nuklearmedizin; 1980 Aug; 19(4):200-5. PubMed ID: 6937874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
